Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GABAPENTIN Cause Transient ischaemic attack? 82 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Transient ischaemic attack have been filed in association with GABAPENTIN (Gabapentin). This represents 0.1% of all adverse event reports for GABAPENTIN.

82
Reports of Transient ischaemic attack with GABAPENTIN
0.1%
of all GABAPENTIN reports
20
Deaths
57
Hospitalizations

How Dangerous Is Transient ischaemic attack From GABAPENTIN?

Of the 82 reports, 20 (24.4%) resulted in death, 57 (69.5%) required hospitalization, and 21 (25.6%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GABAPENTIN. However, 82 reports have been filed with the FAERS database.

What Other Side Effects Does GABAPENTIN Cause?

Drug ineffective (10,914) Drug hypersensitivity (6,833) Off label use (6,729) Drug ineffective for unapproved indication (5,231) Product use in unapproved indication (4,919) Toxicity to various agents (4,839) Completed suicide (4,111) Dizziness (4,107) Somnolence (3,798) Fatigue (3,791)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which GABAPENTIN Alternatives Have Lower Transient ischaemic attack Risk?

GABAPENTIN vs GABAPENTIN ENACARBIL GABAPENTIN vs GADAVIST GABAPENTIN vs GADOBENATE DIMEGLUMINE GABAPENTIN vs GADOBUTROL GABAPENTIN vs GADODIAMIDE

Related Pages

GABAPENTIN Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack GABAPENTIN Demographics